J2997 Alteplase recombinant
Also known as: alteplase, activase
Injection of alteplase recombinant (Activase), a tissue plasminogen activator (t-PA) used as a thrombolytic agent for acute myocardial infarction and stroke.
In Plain Language
clot-dissolving medication
Clinical Context
Used intravenously for acute myocardial infarction, pulmonary embolism, and acute ischemic stroke to dissolve thrombosis.
RVU Information
CPT J2997 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J2997?
CPT J2997 (Alteplase recombinant) is a J Codes (Drugs) code. Injection of alteplase recombinant (Activase), a tissue plasminogen activator (t-PA) used as a thrombolytic agent for acute myocardial infarction and stroke.
How is J2997 administered?
CPT J2997 is administered by a healthcare provider, typically via injection or infusion. Used intravenously for acute myocardial infarction, pulmonary embolism, and acute ischemic stroke to dissolve thrombosis. It is used by Cardiology, Neurology, Emergency Medicine.
When is CPT J2997 used?
Used intravenously for acute myocardial infarction, pulmonary embolism, and acute ischemic stroke to dissolve thrombosis.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.